Nicholas A. LaBella Jr. - Chief Scientific Officer at ZyVersa Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Scientific Officer
Issuer Symbol
ZVSA on OTC
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Nicholas A. LaBella Jr. since 11 Mar 2025

Holdings reported by Nicholas A. LaBella Jr. for ZyVersa Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Stock Options (right to buy) 29,781 12 Dec 2022 Direct Common Stock
Common Stock 18,094 12 Dec 2022 Direct
Warrant (right to buy) 18,094 12 Dec 2022 Direct Common Stock

Transactions reported by Nicholas A. LaBella Jr. for ZyVersa Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.